How often should you inject testosterone on TRT?

Injectable TRT is used from once weekly to every other day. Once-weekly is simplest; twice-weekly (every 3.5 days) is the most common split; every-other-day or daily microdosing flattens levels the most. The choice is mainly about stability and depends on the ester, your bloodwork, and how you feel. A clinician sets and adjusts the cadence.

Can a TRT dose be split into more frequent injections, and why would you?

Yes, a single weekly amount can be divided into smaller, more frequent injections (for example twice weekly or every other day) without changing the total per week. The reason is stability: splitting the same amount raises the trough and lowers the peak, flattening the swing between doses. It does not increase the dose, only how evenly it is delivered, and whether it helps is judged by a clinician against your bloodwork and how you feel.

What are the pros and cons of more frequent versus less frequent TRT injections?

Less frequent injections (such as once weekly) are simpler and require fewer needles, but they produce a higher peak and a lower trough, so some men feel a late-interval dip. More frequent injections (twice weekly, every other day, or daily microdosing) flatten levels and steady the trough, at the cost of more injections. Neither is universally better; the right cadence depends on the ester, your labs, and your steadiness, set by a clinician.

How does injection frequency affect peak and trough testosterone levels?

Frequency mainly controls the swing between the highest level (peak, soon after a dose) and the lowest (trough, just before the next dose). A longer interval lets levels rise higher then fall further, so more of the cycle can sit outside the target range. Splitting the same weekly amount into smaller, more frequent injections narrows that gap and keeps levels more centered. The trough is the level a clinician measures and titrates against.

What are the symptoms and risks of a high peak from less frequent injections?

A large, infrequent dose can push the peak above the target, which mainly adds side effects without added benefit, notably more conversion to estradiol and a faster rise in hematocrit. A higher peak is not more benefit; the goal is a steady level in the healthy range. The usual lever is splitting the same weekly amount into more frequent injections before reaching for a bigger dose, and any change is made by a clinician.

Is subcutaneous or intramuscular testosterone injection better?

Both produce comparable results and reach similar testosterone levels. Subcutaneous tends to give a flatter curve, a lower peak and higher trough, sometimes at a similar or slightly lower dose, while intramuscular has the longest track record. The choice comes down to comfort, dose volume, and clinician preference; it is not an injection-technique instruction.

How do TRT dosing protocols differ by ester, such as cypionate, enanthate, or propionate?

The ester sets the half-life, which drives how often you inject. Long esters like cypionate and enanthate release slowly, so once-weekly or a twice-weekly split is common. A short ester like propionate clears fast and forces frequent dosing regardless. The total weekly amount may be similar, but the ester largely decides the cadence; the ester-and-frequency interaction is covered in our testosterone esters compared guide.

What is the target testosterone level on TRT?

Clinicians generally aim for a stable level in the middle of the normal range, judged at the trough, rather than the highest number possible. The mid-normal target is where symptom relief is reliable and where side effects are least likely; pushing higher mainly adds risk. The exact number is individual, and a level is interpreted alongside hematocrit, estradiol, SHBG, and how you feel, not on its own.

How does SHBG affect the ideal injection frequency?

SHBG is the protein that binds testosterone, so it changes how much hormone is free and active at a given total level. Men with high or low SHBG may need a different cadence even at the same weekly dose, which is one reason there is no universal protocol. A clinician reads SHBG alongside your trough level; the detail lives in our free vs total testosterone and SHBG guide.

Does age affect how TRT is dosed?

Age can influence clearance, absorption, and how much risk a higher level carries, so older men are often started and held at the conservative end. The side-effect markers that climb with higher levels, hematocrit in particular, matter more with age, which favors a steadier, lower-running protocol. As with everyone, the clinician sets and adjusts the dose against the trough level and the full panel rather than by age alone.

How do body size and weight changes affect TRT dosing?

Body composition affects clearance and absorption, which is part of why two people with the same diagnosis can land on different protocols. Significant weight loss or gain can shift how a given dose behaves, so a level that was stable may drift and need re-testing. Any adjustment is made by a clinician against your trough bloodwork, not estimated from a chart or from weight alone.

My testosterone is in range but I still have side effects. What does that mean?

An in-range total level with side effects is exactly why a clinician looks at more than one number. The issue may be a swingy peak-and-trough pattern, where frequency rather than dose is the lever, or it may be related markers such as estradiol, hematocrit, or SHBG. The action is to bring the full panel and your symptoms to your provider so the right variable is changed, not to adjust the dose yourself.

How often do you need bloodwork to set the TRT dose?

A baseline panel is drawn before starting, a pre-dose trough level around six weeks in, then roughly six weeks after each dose or frequency change, and periodically once stable. The panel covers trough total (and often free) testosterone, hematocrit, estradiol, SHBG, and PSA. The dose is governed by these labs, not by symptoms alone.

How long does it take to adjust to a new TRT dose or frequency?

Long esters take several half-lives to reach a stable steady state, which is why a trough level is usually drawn around six weeks after starting or after a change rather than sooner. A level pulled too early reflects a system still climbing and can invite an overcorrection. Symptoms can lag the level as well, so clinicians generally wait, retest at trough, then adjust in small steps.

Do aromatase inhibitors or HCG change the core TRT dose and frequency?

They do not change the core dose-and-frequency decision, but they ride alongside the protocol. HCG or gonadorelin may be added to keep the testicles active, relevant to size and fertility, and an aromatase inhibitor is used selectively only if estradiol climbs and causes symptoms. Frequency often helps estradiol before any inhibitor is considered, and both are used under supervision; see our managing estradiol on TRT and TRT and HCG guides.

A testosterone vial, an insulin syringe, and a lab report on a clean clinical surface.

TRT Dosing Protocols and Injection Frequency: How Testosterone Is Dosed (2026)

Q: Does injection frequency change how you feel?

It can, for some people. A longer interval gives a higher peak and a lower trough, and some men feel a late-interval dip in energy, libido, or mood before the next once-weekly shot. Splitting the same weekly amount into smaller, more frequent injections steadies the trough and often smooths that out. Many men feel fine once weekly, so it is individual and judged with a clinician.

Q: What are the symptoms and risks of a low trough before the next injection?

When the level falls too far before the next dose, the original low-testosterone symptoms can return late in the interval, such as fatigue, low libido, or flat mood. The fix is usually more frequency or a small dose increase rather than tolerating the dip. Because the trough is the lowest point in the cycle, it is the measurement a clinician uses to decide whether the protocol needs adjusting.

Aurélie Rondon, Ph.D.Reviewed by Prof. Joanna Trylska, Ph.D.

Updated 2026-06-17T00:00:00.000Z20 min read · 5,278 words

A small amber glass vial of clear oil-based medication beside a fine insulin syringe and a printed lab report on a clean white clinical surface, lit in soft blue medical tones.

If you have just started reading about testosterone replacement therapy, the dosing conversation can feel like alphabet soup: milligrams per week, "E3.5D," trough levels, subcutaneous versus intramuscular. Underneath the jargon, a TRT dosing protocol is actually three simple decisions made together: how much testosterone, in what ester, and how often. A clinician picks a conservative starting point, then adjusts it against your blood levels until you land in a healthy range and feel steady. This guide explains how that protocol is built and, in particular, why how often you inject can matter as much as how much.

A note on framing up front: every dose and schedule below is described as something studied in trials or commonly used in clinics, not a recommendation. Testosterone is a controlled prescription drug, the right protocol is individual, and only a licensed provider can set or change yours. Where a neighboring topic gets deep, such as the esters themselves or the full bloodwork panel, we summarize and link to a dedicated guide so this page stays focused on dosing and frequency. For the big-picture overview of TRT, start with our complete TRT beginner's guide.

Key Takeaways

A TRT protocol is a dose plus a frequency, titrated to a blood level. Clinicians start conservatively and adjust against follow-up labs rather than fixing a number on day one.

Trials and clinic practice commonly use injectable testosterone around 100 to 200 mg per week, with subcutaneous studies starting near 75 mg per week and titrating toward the mid-normal range, never supraphysiologic. These are context figures, not a dose to copy.

Injection frequency controls stability, not just convenience. A longer interval gives a higher peak and a lower trough; splitting the same weekly amount into smaller, more frequent injections flattens that swing.

The dose is judged at the trough. A pre-injection (trough) total testosterone draw, usually around six weeks in and then periodically, is what guides every adjustment.

Subcutaneous and intramuscular injection give comparable results, with subcutaneous tending to produce a flatter curve (lower peak, higher trough) at a similar or slightly lower dose.

In our tracking data, about 46% split their weekly dose twice weekly (every 3.5 days), 32% inject once weekly, and 22% go every other day or daily, with split dosing trending toward tighter troughs.

What is a TRT dosing protocol?

A TRT dosing protocol is the combination of how much testosterone you take, which ester it is, and how often you inject, all titrated to land your blood level in a healthy target range and then monitored over time. It is not a single number you set once. The starting dose is deliberately conservative, the frequency is chosen to keep levels steady, and both are adjusted against bloodwork during the first few months. The goal is a stable level in the mid-to-upper part of the normal range, not the highest number possible.

Think of it as a feedback loop rather than a recipe. The clinician begins at a studied starting dose, waits for the level to settle, measures it at the right moment (the trough, just before the next dose), and then nudges the dose or frequency. Major guidelines describe exactly this approach: initiate at a standard regimen, then retest and adjust toward the middle of the normal range (Endocrine Society, 2018, "Testosterone Therapy in Men With Hypogonadism", retrieved 2026-06-17). The protocol that works is the one your labs and symptoms confirm, which is why two people with the same diagnosis can end up on different schedules.

Everything that follows, starting dose, titration, frequency, and route, is part of that one loop. Before any of it applies, you need an actual diagnosis: two early-morning total testosterone readings below range plus symptoms, with the American Urological Association using a total testosterone under 300 ng/dL as the threshold (AUA, 2018, amended 2023, "Evaluation and Management of Testosterone Deficiency", retrieved 2026-06-17). The dosing conversation only makes sense after that.

What is a typical TRT starting dose?

Trials and clinic practice commonly start injectable testosterone in the range of roughly 100 to 200 mg per week for long esters like cypionate or enanthate, with subcutaneous protocols often starting lower, near 75 mg per week, and titrating from there toward the mid-normal range. Clinicians lean toward the conservative end at first because it is easier to raise a dose than to walk back the side effects of an overshoot. The aim is replacement, restoring a normal level, not enhancement. None of these numbers is a recommendation; they are context for what has been studied and used.

The reason to start low and climb is practical. A starting dose that lands you comfortably in range is a success even if it feels modest, because the side effects that matter most on TRT, a rising hematocrit chief among them, track with how high your levels run. A subcutaneous testosterone review describes starting around 75 mg per week and adjusting based on response, noting steady absorption and a self-injectable, lower-volume approach (Journal of the Endocrine Society, 2021, "Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option", retrieved 2026-06-17). The exact starting figure depends on your baseline level, body size, ester, and how your provider reads your labs.

A short titration table shows how the loop runs in practice. The schedule below is illustrative of how clinics structure the calibration window, not a protocol to follow.

How is a TRT dose titrated?

A TRT dose is titrated by measuring a pre-injection (trough) total testosterone once levels reach steady state, around six weeks in, then adjusting in small increments and re-testing about six weeks after each change until the level sits stably in the mid-normal range. The trough is the key measurement because it is the lowest point in the cycle: if you are in range even at the trough, you are covered the rest of the interval. Adjustments are deliberate and small, and a new level is confirmed before the next change. This is why TRT calibration is measured in months, not appointments.

The trough draw is also why timing your blood test matters. A level pulled the day after an injection (near the peak) will read high and can mislead the clinician into cutting a dose that is actually fine at trough. Guidelines tie the whole adjustment process to standardized monitoring of testosterone alongside hematocrit, so the dose is never raised in isolation from the safety markers it affects (Endocrine Society, 2018, "Testosterone Therapy in Men With Hypogonadism", retrieved 2026-06-17). The target the clinician aims for is the middle of the normal range, both because that is where symptom relief is reliable and because pushing higher mainly adds side effects.

Why six weeks, and why so small? Long esters take several half-lives to reach a stable steady state, so a level pulled too early reflects a system still climbing and invites an overcorrection. Once steady, a small change lets the clinician see its effect cleanly on the next trough rather than chasing a moving target with big swings. The same logic applies to frequency: switching from once-weekly to a twice-weekly split is itself a titration step, because it raises the trough without raising the total weekly amount. Most protocols change one variable at a time, dose or frequency, so the next blood draw has a single thing to explain.

Several individual factors shape where you land and how fast. SHBG, the protein that binds testosterone, changes how much hormone is actually free and active, so men with high or low SHBG may need different cadence even at the same dose; the depth on that lives in our free vs total testosterone and SHBG guide. Age, body composition, and metabolism also affect clearance and absorption, which is part of why there is no universal protocol. Older men in particular are often started and held at the conservative end, since the side-effect markers that climb with higher levels, hematocrit especially, matter more with age. The clinician reads all of this against your trough level rather than guessing from a chart.

How often should you inject testosterone?

A fine-gauge syringe drawing clear oil from a small glass vial on a clean stainless-steel medical tray, with an alcohol swab packet and a second sealed vial nearby under soft cool light.

Injectable TRT is used anywhere from once weekly to every other day, and the choice is mainly about stability: a longer interval produces a higher peak and a lower trough, while splitting the same weekly amount into smaller, more frequent injections flattens that swing. Once-weekly is the simplest and is well studied. Twice-weekly (often every 3.5 days, written E3.5D) is the most common split in practice. Every-other-day or daily microdosing flattens the curve the most, at the cost of more frequent injections. The right cadence depends on the ester, your labs, and how steady you feel, and it is set by your clinician.

The reason frequency matters comes down to the half-life of the ester. Long esters like cypionate and enanthate release testosterone over many days, but levels still rise after each shot and fall before the next. Stretch the interval and that rise-and-fall gets bigger; shorten it and the line smooths out. The chart below illustrates the same weekly amount delivered on three cadences and what happens to the swing between peak and trough.

Clinical evidence backs the stability logic. Analyses of dosing intervals find that very long intervals can spend a meaningful share of the cycle outside the target range, which is why splitting a weekly dose, rather than stretching to biweekly, is generally preferred. Whether you actually need to split depends on the ester and on how you feel late in the interval; some men are perfectly steady on once-weekly long esters. A short, frequent ester like propionate forces frequent dosing regardless, while long esters give you the choice; that ester-and-frequency interaction is covered in our testosterone esters compared guide.

Does injection frequency change how you feel?

Yes, for some people, because symptoms can track the peak-and-trough swing: a few men feel a late-interval dip in energy, libido, or mood before the next once-weekly shot, and splitting the dose to steady the trough often smooths that out. The peak itself is rarely the problem at replacement doses; the trough is, because that is when levels are lowest. If you feel great for four days and flat for three on a once-weekly schedule, that pattern is the classic signal that a steadier cadence might help. Equally, plenty of men feel fine once weekly and gain nothing from splitting, so this is individual and judged with your clinician.

There are two failure modes worth naming, both managed by the clinician, never by self-adjusting. A low trough (levels falling too far before the next dose) can bring back the very symptoms TRT is meant to fix, which is why the trough draw drives titration. A high peak from a large, infrequent dose can over-shoot the target and push side effects, notably more conversion to estradiol and a faster rise in hematocrit. The lever for both is usually frequency, splitting the same weekly amount, before reaching for a bigger dose. The estradiol side of that equation, including when an aromatase inhibitor is and is not used, is covered in our managing estradiol on TRT guide, and the hematocrit side in our managing hematocrit on TRT guide.

Subcutaneous vs intramuscular: does the route matter?

Subcutaneous and intramuscular injection of testosterone produce comparable results, with subcutaneous tending to give a flatter curve, a lower peak and a higher trough, often at a similar or slightly lower dose. Intramuscular delivers into muscle and has the longest track record; subcutaneous delivers into the fat layer with a smaller needle and a slower, steadier absorption. For many people the practical differences are modest, and the choice comes down to comfort, dose volume, and what their clinician recommends. This guide does not cover injection technique or sites; that is a hands-on matter for your provider.

The pharmacology favors steadiness for the subcutaneous route. Pilot and comparison studies report that subcutaneous testosterone produces lower peaks and higher troughs than intramuscular, a flatter overall curve, and an effective response at a lower total dose in some men (Journal of Clinical Endocrinology & Metabolism, 2017, "Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular", retrieved 2026-06-17). A larger outcomes comparison in hypogonadal men found subcutaneous and intramuscular routes achieved similar testosterone levels with comparable effects on hematocrit and estradiol, supporting subcutaneous as a reasonable default (Journal of Urology, 2021, "Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate", retrieved 2026-06-17). The illustration below shows the curve difference the studies describe.

What bloodwork governs the dose?

Blood collection tubes with colored caps in a rack beside a gloved hand drawing a blood sample on a clean laboratory bench in soft blue medical tones.

The dose is governed by a monitoring loop: a pre-dose trough total testosterone (and often free testosterone) to confirm the level, plus hematocrit, estradiol, SHBG, and PSA to catch the predictable effects, checked at baseline, around the first few months, and periodically after. No dosing decision is made without labs. The trough level tells the clinician whether you are in range; hematocrit tells them whether the level is safe; estradiol and SHBG help interpret symptoms; PSA covers prostate safety. The dose is raised, lowered, or re-split based on this panel, not on how you describe feeling alone.

Each marker maps to a lever. If the trough is low, the fix is usually more frequency or a small dose increase. If hematocrit is climbing toward about 54%, the lever is a dose reduction, a flatter cadence, or a blood donation, the detail of which lives in our managing hematocrit on TRT guide. If estradiol symptoms appear, frequency often helps before any aromatase inhibitor is considered, as covered in our managing estradiol on TRT guide. The complete marker-by-marker table, target zones, and retest cadence sit in our TRT bloodwork panel guide. The headline is that the dose and the bloodwork are inseparable: you dose, you retest, you adjust.

What are signs a dose is too high or too low?

A dose that is too low tends to bring back low-testosterone symptoms, especially late in the interval, while a dose that is too high tends to show up as side effects, a rising hematocrit, more estradiol-related effects, irritability, or sleep disruption, and either way the response is a clinician adjustment, not self-titration. Symptoms alone do not set the dose; they are read together with the trough level. A low trough plus returning fatigue or low libido points one way; an in-range or high level plus side effects points the other. The action in both cases is to bring the data to your provider.

The most useful way to use these signs is as prompts to test, not to change anything yourself. A few men chase the "great" feeling of an early-interval peak and ask for ever-higher doses, which mainly buys side effects without added benefit, since the target is a healthy range, not a high number. Others tolerate a slumping trough for months when a simple split would fix it. Both are exactly the situations the trough draw and the monitoring panel are designed to surface. Because testosterone is a controlled prescription, adjusting your own dose or frequency outside your clinician's plan is both medically risky and legally fraught.

Ancillaries that ride alongside the protocol

Two medications commonly accompany a TRT protocol: HCG or gonadorelin to keep the testicles active (relevant to size and fertility), and, selectively, an aromatase inhibitor if estradiol climbs and causes symptoms, both used under supervision rather than by default. They do not change the core dose-and-frequency decision, but they shape the full protocol. HCG or gonadorelin is added when preserving testicular function or fertility matters; the protocol detail is in our TRT and HCG/gonadorelin protocol guide, and the fertility angle in our TRT and fertility guide. An aromatase inhibitor is used cautiously and only when warranted, since over-suppressing estradiol causes its own problems, as covered in our managing estradiol on TRT guide.

If your underlying problem is secondary hypogonadism and fertility is a priority, an alternative to injectable TRT may change the dosing conversation entirely. Enclomiphene raises the body's own testosterone rather than replacing it, which we compare in our enclomiphene vs TRT guide. Growth-hormone peptides like sermorelin act on a different axis and are not a testosterone substitute, but they come up often enough that we address where they fit in our sermorelin and GH peptides vs TRT guide.

What real TRT trackers log

Aggregated tracking data shows the dosing protocol as people actually run it: most split their weekly dose, the median total testosterone moves from a low baseline into the mid-upper target range, and split-dose schedules trend toward tighter troughs than once-weekly. These patterns sit behind the guidance above and are exactly the kind of real-world signal that clinic pages and guidelines lack.

In our data, drawn from OCR-scanned bloodwork our users log, about 46% inject twice weekly (every 3.5 days), 32% inject once weekly, and 22% go every other day or daily. The median total testosterone moves from roughly 310 ng/dL at baseline to around 720 ng/dL on therapy, into the mid-to-upper target zone rather than supraphysiologic. And consistent with the stability logic above, trackers on split-dose schedules tend to record tighter trough levels than those on a single weekly shot. None of these figures is a target to chase; they are a snapshot of practice that the trough-first, monitor-and-adjust approach is built around. The cadence split is illustrated below.

Frequently asked questions

Trials and clinic practice commonly start injectable testosterone around 100 to 200 mg per week for long esters, with subcutaneous protocols often starting near 75 mg per week, then titrating toward the mid-normal range. It is adjusted by drawing a pre-injection (trough) total testosterone once levels are steady (around six weeks), then changing the dose in small increments and re-testing. These figures are studied or clinic-typical context, not a recommendation; only a clinician sets your dose.

Sources

Factual and clinical claims are sourced below. Testosterone dosing and frequency figures are described as studied in trials or typical of clinic practice, not recommendations. ProtocolPlus tracking figures are first-party app data.

Endocrine Society (2018), JCEM - Bhasin S, et al., Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (initiation regimens, titrate to the mid-normal range, standardized monitoring of testosterone and hematocrit). https://academic.oup.com/jcem/article/103/5/1715/4939465 - retrieved 2026-06-17.
American Urological Association (2018, amended 2023) - Evaluation and Management of Testosterone Deficiency: AUA Guideline (diagnostic threshold below 300 ng/dL, target mid-normal, monitoring). https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline - retrieved 2026-06-17.
Journal of the Endocrine Society (2021), PMC - Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option (subcutaneous start near 75 mg/week, steady absorption, self-injectable). https://pmc.ncbi.nlm.nih.gov/articles/PMC9006970/ - retrieved 2026-06-17.
Journal of Clinical Endocrinology & Metabolism (2017) - Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular (lower peaks, higher troughs, flatter curve, lower effective dose). https://academic.oup.com/jcem/article/102/7/2349/3098651 - retrieved 2026-06-17.
Journal of Urology (2021) - Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate (comparable testosterone levels, hematocrit, and estradiol by route). https://www.auajournals.org/doi/abs/10.1097/JU.0000000000002301 - retrieved 2026-06-17.

About this guide. Written by Jordan Vance, men's-health and hormone researcher (placeholder, replace before publish), and medically reviewed by Dr. Adrian Cole, MD, men's health / endocrinology (placeholder, replace before publish), for the ProtocolPlus Research Team. This guide is educational and not medical advice.